A Phase II Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon in Patients with MGMT Unmethylated Glioblastoma
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
![Photograph of Douglas Ney](https://som.ucdenver.edu/FIMS/Content/faculty/3341/CU-Doctors-3341.jpg)
Douglas Ney
Study ID
Protocol Number: 23-1257
More information available at ClinicalTrials.gov: NCT05789589
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers